PhRMA and Johnson & Johnson filed briefs backing Novartis and United Therapeutics's appeals of U.S. District Judge Dabney Friedrich’s ruling in their 340B contract pharmacy lawsuits.

PhRMA and J&J File Amicus Briefs in Support of Novartis and United Therapeutics

Pharmaceutical Research and Manufacturers of America and drug maker Johnson & Johnson each filed a friend of the court brief in June backing Novartis and United Therapeutics in those two companies’ appeals of a federal district judge’s November decision that while the 340B statute does not stop manufacturers from imposing any conditions on offers of 340B pricing, the statute does not permit all such conditions.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report